Status:
TERMINATED
Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Necrotizing Enterocolitis
Sepsis
Eligibility:
All Genders
Phase:
NA
Brief Summary
We hypothesize that supplementing maternal diet with probiotics will decrease the incidence of feeding intolerance, necrotizing enterocolitis and sepsis in preterm infants fed breastmilk.
Detailed Description
Oral probiotics have previously been shown to prevent necrotizing enterocolitis in preterm infants. A few reports of sepsis by a probiotic bacteria have impeded implementation of oral probiotic supple...
Eligibility Criteria
Inclusion
- Mothers of preterm infants
- Pumping breast milk
Exclusion
- Neonatal congenital anomalies
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT00835874
Start Date
June 1 2007
End Date
July 1 2009
Last Update
August 2 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv Medical Center
Tel Aviv, Israel, 64239